Overview of the Standing Operating Procedure (SOP) for the development of Provisional Advisory Levels (PALs)

Inhalation Toxicology

Volumn 21, Issue SUPPL. 3, 2009, Pages 1-11

  Young, Robert A ^a   Bast, Cheryl B ^a   Wood, Carol S ^a   Adeshina, Femi ^b  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Drinking water; Inhalation; PAL; Risk assessment; SOP

Indexed keywords

CHLORINE; DRINKING WATER; FORMALDEHYDE; NITROGEN DIOXIDE; OZONE; SULFUR DIOXIDE; SULFURIC ACID; TOXIC SUBSTANCE;

ADVISORY COMMITTEE; AIR QUALITY; DATA ANALYSIS; DOCUMENTATION; ECOTOXICITY; EXPOSURE; HUMAN; INFORMATION PROCESSING; INHALATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVISIONAL ADVISORY LEVEL; REVIEW; RISK ASSESSMENT; STANDING OPERATING PROCEDURE; WATER QUALITY;

AIR POLLUTANTS; ANIMALS; CONSULTANTS; ENVIRONMENTAL EXPOSURE; HUMANS; INHALATION EXPOSURE; REFERENCE STANDARDS; UNITED STATES; WATER POLLUTANTS; WATER SUPPLY;

EID: 76449112443     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958370903202747     Document Type: Review

References (37)

1. Barnes DG, Dourson ML. 1988. Reference Dose (RfD): Description and use in health risk assessments. Regul Toxicol Pharmacol 8:471-486.
2. Bedi JF, Horvath SM, Folinsbee LJ. 1982. Human exposure to sulfur dioxide and ozone in high temperature-humidity environment Am Ind Hyg Assoc J 43: 26-30.
3. Bethel RA, Sheppard D, Geffroy B, Tam E, Nadel JA, Boushey HA. 1985. Effect of 0.25 ppm sulfur dioxide on airway resistance in freely breathing heavily exercising asthmatic subjects. Am Rev Respir Dis 131:659-661.
4. D'Alessandro A, Kuschner W, Wong H, Boushey HA, Blanc PD. 1996. Exaggerated responses to chlorine inhalation among persons with nonspecific airway hyperreactivity. Chest 109:331-337.
5. de Jong RH, Eger EI. 1975. AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology 42:384-389.
6. Delic JI, Lilly PD, MacDonald AJ, Loizou GD. 2000. The utility of PBPK in the safety assessment of chloroform and carbon tetrachloride. Reg Toxicol Pharmacol 32:144-155.
7. Dourson ML. 1994. Methods for estimating oral reference doses (RfDs) In: Mertz W, Abernathy CO, Olin SS, eds. Risk Assessment of Essential Elements. Washington, DC: ILSI Press, 51-61.
8. Dourson ML, Felter SP, Robinson D. 1996. Evolution of science-based uncertainty factors in noncancer risk assessment. Reg Toxicol Pharmacol 24:108-120.
9. Dourson ML, Knauf LA, Swartout JC. 1992. On Reference Dose (RfD) and its underlying toxicity data base. Toxicol Ind Health 8:171-189.
10. Dourson ML, Stara JF. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol 3:224-238.
11. Fowles JR, Alexeeff GV, Dodge D. 1999. The use of benchmark dose methodology with acute inhalation lethality data. Regul Toxicol Pharmacol 29:262-278.
12. Gregory GA, Eger EI, Munson ES. 1969. The relationship between age and halothane requirement in man. Anesthesiology 30:488-491.
13. Hackney JD, Thiede FC, Linn WS, Pedersen EE, Spier CE, Law DC, Fischer DA. 1978. Experimental studies on human health effects of air pollutants. IV. Short-term physiological and clinical effects of nitrogen dioxide exposure. Arch Environ Health 33:176-181.
14. Horstman DH, Ball BA, Brown J, Gerrity T, Tolinsbee LJ. 1995. Comparison of pulmonary responses of asthmatic and nonasthmatic subjects performing light exercise while exposed to a low level of ozone. Toxicol Ind Health 11:69-85.
15. Koenig JQ, Dumler K, Rebolledo V, Williams PV, Pierson WE. 1993. Respiratory effects of inhaled sulfuric acid on senior asthmatics and nonasthmatics. Arch Environ Health 48:171-175.
16. Litchfield JT Jr, Wilcoxon F. 1948. A simplified method of evaluating doseeffect experiments. J Pharmacol Exp Ther 96:99-113.
17. Morrow PE, Utell MJ, Bauer MA, Spears DM, Gibb FR. 1994. Effects of near ambient levels of sulfuric acid aerosol on lung function in exercising subjects with asthma and chronic pulmonary disease. In: Dodgson J, McCallum R I, eds. Inhaled particles VII: Proceedings of an international symposium September 1991; Edinburgh, UK.
18. Ann Occup Hyg 38(Supp 1):933-938.
19. NRC (National Research Council). 1993. Guidelines for Developing Community Emergency Exposure Levels for Hazardous Substances. Washington, DC: National Academy Press.
20. NRC (National Research Council). 2001. Standing operating procedures for Developing Acute Exposure Guideline Levels for Hazardous Substances. Washington, DC: National Academy Press.
21. Paustenbach DJ, Carslon GP, Christian JE, Born GS. 1986a. A comparative study of the pharmacokinetics of carbon tetrachloride in the rat following repeated inhalation exposures of 8 and 115 hr/day. Fundam Appl Toxicol 6: 484-497.
22. Paustenbach DJ, Christian JE, Carslon GP, Born GS. 1986b. The effect of an 115-hr/day exposure schedule on the distribution and toxicity of inhaled carbon tetrachloride in the rat. Fundam Appl Toxicol 6:472-483.
23. Paustenbach DJ, Clewell HJ III, Gargas ML, Andersen ME. 1988. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. Toxicol Appl Pharmacol 96:191-211.
24. Rhinehart WE, Hatch T. 1964. Concentration-time product (CT) as an expression of dose in sublethal exposures to phosgene. Ind Hyg J 25:545-553.
25. Rotman HH, Fliegelman MJ, Moore T, Smith RG, Anglen DM, Kowalski CJ, Weg JG. 1983. Effects of low concentration of chlorine on pulmonary function in humans. J Appl Physiol 54:1120-1124.
26. Sander LR, Green DL, Chapman MD, Kulle TJ. 1987. Acute pulmonary response of asthmatics to 30 ppm formaldehyde. Toxicol Ind Health 3:569-578.
27. Stacy RW, House D, Friedman M, Hazucha M, Greene J, Raggio L, Roger LJ. 1981. Effects of sulfur dioxide on pulmonary function parameters of normal human subjects. Arch Environ Health 36:172-178.
28. ten Berge WF, Zwart A, Appelman LM. 1986. Concentration-time mortality response relationship of irritant and systemically acting vapours and gases. J Hazard Mater 13:301-309.
29. US EPA (United States Environmental Protection Agency). 1980. Guidelines and Methodology Used in the Preparation of Health Assessment Chapters of Consent Decree Water Quality Criteria. Fed Reg 45:79347-79357.
30. US EPA (United States Environmental Protection Agency). 1984. Methodology and Guidelines for Ranking Chemicals Based on Chronic Toxicity Data. Office of Emergency and Remedial Response, Environmental Criteria and Assessment Office, Cincinnati, OH. ECAO-CIN-R263, November, 1984.
31. US EPA (United States Environmental Protection Agency). 1989. Risk assessment guidance for Superfund: Vol 1. Human health evaluation manual (part A). EPA/540/1-89/002. Office of Emergency and Remedial Response, US Environmental Protection Agency, Washington, DC.
32. US EPA (United States Environmental Protection Agency). 1990. Exposure Factors Handbook. EPA/600/8-89/043. Office of Health and Environmental Assessment, Washington, DC.
33. US EPA (United States Environmental Protection Agency). 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F. Environmental Criteria and Assessment Office, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC.
34. US EPA (United States Environmental Protection Agency). 1995. The Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/ R-94/2007. Risk Assessment Forum, US Environmental Protection Agency, Washington, DC.
35. US EPA (United States Environmental Protection Agency). 2006. Protection for Subjects in Human Research: Final Rule 40CFR Parts 9 and 26. Fed Reg 7:6128-6176.
36. US EPA (United States Environmental Protection Agency). 2007. Benchmark Dose Software Draft Beta Version 1.4.1. National Center for Environmental Assessment Office of Research and Development.
37. Utell MJ, Morrow PE, Hyde RW. 1993. Comparison of normal and asthmatic subjects' responses to sulfate pollutant aerosols. Ann Occup Hyg 26: 691-697.